The agency must give outside scientists and the public the opportunity to see the data and the FDA’s reasoning before coming to such a decision, critics say.
Mapping the COVID-19 ‘family tree’
It is likely we’ll eventually have a coronavirus vaccine — but perhaps not as quickly as some expect. From development, to clinical trials and distribution, there are tremendous challenges lying ahead.
Findings may help explain why these energy-producing cellular organelles begin to fail as we age.
Medical supply companies with boards that included at least two women recalled life-threatening products almost a month sooner than those with all-male boards,
From the research lab to your doctor’s office – here’s what happens in phase 1, 2, 3 drug trials
Convalescent plasma treatment involves using plasma from people who have recovered from COVID-19 and infusing it into patients who currently have the disease.
Knowing the result of a test allows rational individual decisions.
The study will follow patients who contract COVID-19 to learn why some die, some recover, and some are asymptomatic.
The phone app could diagnose illness sooner, preventing members of the military and civilians who are ill from returning to work or school too soon.
There is not a single Trilogy Evo Universal ventilator inn the U.S. stockpile. Meanwhile, Royal Philips N.V. has sold higher-priced version around the world.
Instead of trying to create a new drug, some scientists are looking to see if there are any drugs available today that can fight the coronavirus.
Despite older, sicker patients, mortality rate dropped by one-third within 10-year period
A huge proportion of medical research is funded by industry even though studies show company-sponsored studies tend to overstate benefits, playdown harms.